We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$263M
1-Year Est. Return
61.9%
This Fund
S&P 500
This Quarter
Est. Return
-0.06%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$118M
AUM Growth
-$19.3M
(-14%)
Cap. Flow
-$15.2M
Cap. Flow
% of AUM
-12.84%
Top 10 Holdings %
Top 10 Hldgs %
33.71%
Holding
142
New
22
Increased
24
Reduced
43
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oshkosh
OSK
|
+$2.52M |
| 2 |
FSB
Franklin Financial Network, Inc.
FSB
|
+$2.24M |
| 3 |
Hackett Group
HCKT
|
+$1.81M |
| 4 |
Applied Optoelectronics
AAOI
|
+$1.81M |
| 5 |
Olin
OLN
|
+$1.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACOR
Acorda Therapeutics
ACOR
|
+$4.22M |
| 2 |
SONC
Sonic Corp
SONC
|
+$3.58M |
| 3 |
MSCC
Microsemi Corp
MSCC
|
+$3.41M |
| 4 |
ATML
ATMEL CORP
ATML
|
+$3.06M |
| 5 |
CMBT
CMB.TECH NV
CMBT
|
+$2.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.44% |
| 2 | Industrials | 14.67% |
| 3 | Healthcare | 12.54% |
| 4 | Financials | 11.39% |
| 5 | Consumer Discretionary | 7.25% |
Similar funds
KA
LCGC
DEA
EAN
PIP
VIG
SC
L
1492 Capital Management's Q1 2016 Portfolio in Review
As of Q1 2016, 1492 Capital Management held 142 positions worth $118M, down 14% from $138M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
1492 Capital Management withdrew a net $15.2M in Q1 2016, closing 31 positions and reducing 43 holdings. Its most notable exit was Acorda Therapeutics, an estimated $4.22M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, 1492 Capital Management opened a new position in Oshkosh worth $2.92M.
- 1492 Capital Management's largest Q1 2016 buy was Oshkosh: 71,369 shares worth $2.92M.
- 1492 Capital Management added most to Franklin Financial Network, Inc. in Q1 2016, an estimated $2.24M increase.
- 1492 Capital Management's biggest Q1 2016 reduction was Microsemi Corp, cutting an estimated $3.41M.
- 1492 Capital Management fully exited Acorda Therapeutics in Q1 2016, selling an estimated $4.22M.
- 1492 Capital Management's ten largest holdings make up 34% of its $118M portfolio in Q1 2016.
- 1492 Capital Management opened 22 new positions and closed 31 in Q1 2016.
- 1492 Capital Management's portfolio value fell 14% quarter-over-quarter to $118M.
Based on 1492 Capital Management's 13F filing for Q1 2016, filed 11 May 2016.